
M-Power New York City:
Community Workshop
Know the risks and symptoms of multiple myeloma, the most common blood
cancer in African Americans, and how to get the best care.
In collaboration with Memorial Sloan Kettering Cancer Center
with support from:
2seventy bio, Amgen, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Karyopharm Therapeutics, Pfizer, Takeda Oncology, The Binding Site
%
of all cases of myeloma are in African Americans
more common in African Americans
%
of all newly diagnosed myeloma patients will be African American
Multiple Myeloma
Did you know that myeloma is the most common blood cancer in people of African descent? But doctors do not typically check people for myeloma during a regular visit because currently there are no national screening recommendations for myeloma.
That’s why it’s important to learn the early symptoms of myeloma and let your doctor know that you—or a friend or family member—are at added risk for the disease.
Because even though myeloma affects African Americans at greater rates, with early diagnosis and treatment, African Americans can have better overall survival in living with the disease.
MYELOMA TOOLKIT
A Day in the Life –
Terrence and Toni Green
You’re listening to A Day in the Life Podcast, brought to you by the International Myeloma Foundation. We hope this podcast provides messages of hope and resilience for those in the myeloma community and beyond. Today we’re talking to myeloma patient Terrence Green and his spouse and care partner Toni Green.
Abstracts on racial disparities in myeloma care
IMF Chief Medical Officer Dr. Joseph Mikhael (TGen, City of Hope — Phoenix) talks about abstracts on racial disparities in myeloma care as reported from this year’s American Society of Hematology (ASH) annual conference held in Atlanta, GA.
Patient advocate Yelak Biru shares his story
Diagnosed at the young age of 25 with stage III multiple myeloma, Yelak Biru is a patient turned myeloma research advocate. Working with a team of medical practitioners and educating himself through support group leadership, information resources, advocacy sites, social media, and the IMF, Yelak has successfully integrated myeloma to his life for over two decades.